BioSpace News Archive

FDA

Cure Rare Disease Receives FDA Approval to Administer First-in-Human CRISPR Therapeutic

Cure Rare Disease - a Boston-based 501c3 nonprofit biotech - announces the approval from the U.S. Food and Drug Administration to administer its very first therapeutic.

August 10, 2022
·
4 min read
Lone Star Bio

Caris’ Precision Oncology Alliance Welcomes the OU Health Stephenson Cancer Center

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize health care, announced that OU Health Stephenson Cancer Center has joined the Caris Precision Oncology Alliance™.

August 10, 2022
·
5 min read
Business

Nuvalent Highlights Execution Across Pipeline of Novel Kinase Inhibitors and Reports Second Quarter 2022 Financial Results

Nuvalent, Inc., a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, reported pipeline progress and second quarter 2022 financial results.

August 10, 2022
·
8 min read
Business

Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2022 and Reiterates Key Anticipated Near-Term Milestones

Outlook Therapeutics, Inc. today announced its financial results for its fiscal third quarter ended June 30, 2022.

August 10, 2022
·
11 min read
Lone Star Bio

UC Davis’ new research shows how total-body PET imaging can assess the immunological response to COVID-19 infections

UC Davis, a leading university in molecular imaging that collaborated with United Imaging to develop the world’s first total-body PET/CT scanner, ‘uEXPLORER®,’ recently presented their research on COVID-19 at the 2022 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

August 10, 2022
·
3 min read
FDA

MEDICALGORITHMICS secures FDA approval for DeepRhytmAI technology

Medicalgorithmics has received FDA approval in the U.S. for its proprietary next generation system in ECG signal analysis called DeepRhytmAI.

August 10, 2022
·
2 min read
BioMidwest

VieCure Partners with Clarified Precision Medicine to Accelerate the Adoption of Precision Oncology

VieCure, a cancer care company with a market leading artificial intelligence, informatics, and clinical decision support platform, announced a new strategic collaboration with Clarified Precision Medicine which will make precision oncology more accessible for patients and community oncologists.

August 10, 2022
·
5 min read
Business

SAB Biotherapeutics Provides Company Update for Q2 2022 Financial ResultsExpects cash is sufficient to fund operations for the forward twelve months

SAB Biotherapeutics today reported financial results for the second quarter ended June 30, 2022 and provided a company update.

August 10, 2022
·
6 min read
Versant Ventures Launches Vector BioPharma AG

Versant Ventures today announced the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform that is devoid of viral genes.

August 10, 2022
·
5 min read
Business

Albireo Appoints New Members to Board of Directors

Albireo Pharma, Inc. (Nasdaq: ALBO), today announced the appointments of Habib Dable and Susan Alesina to its Board of Directors — two experienced, strategic leaders with vast pharmaceutical and biotech expertise in business development, operations and commercialization.

August 10, 2022
·
11 min read